Osama Mohamad

8PUBLICATIONS
50CO-AUTHORS
Radiation therapyPredictive and prognostic markersHuman impacts of climate change and human adaptationEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 14, 2025
Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled Trial.

Comron Hassanzadeh, Deborah Kuban, Sarah Pasyar

|May 09, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials.

Mack Roach, Jingbin Zhang, Osama Mohamad

|Apr 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials.

Andrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju

|Oct 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.

Jonathan David Tward, Huei-Chung Huang, Andre Esteva

|Feb 15, 2024
Reducing the Environmental Impact of Health Care Conferences: A Study of Emissions and Practical Solutions.

Katie E Lichter, Ali Sabbagh, Sasha Demeulenaere

|Jun 15, 2023
Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey.

Ali Sabbagh, Jessica Weiss, Bouchra Tawk

Pageof 2

Frequent Collaborators

4 joint publications

Felix Y Feng

3 joint publications

Daniel E Spratt

3 joint publications

Phuoc T Tran

3 joint publications

Howard M Sandler